Overview

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.
Phase:
Phase 4
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Treatments:
Tacrolimus